As reported by a previous literature, miR-525-5p was verified to be a tumor suppressor in cervical cancer via hampering epithelial-to-mesenchymal transition and anoikis resistance through UBE2C/ZEB1/2 signaling pathway [33]. Here, UBE2C is linked to cervical carcinoma.